Robert J. Glaser
Vorstandsvorsitzender bei Corporate Call Center, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Krishnamurthy V. Tenneti | M | 79 |
Indegene Ltd.
 Indegene Ltd. Miscellaneous Commercial ServicesCommercial Services Indegene Ltd. engages in the provision of healthcare support, media, and technology services to the pharmaceutical and biotechnology sectors. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation and Others segment. The Enterprise Medical Solutions segment establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The Enterprise Commercial Solutions segment involves in assisting life sciences companies with their digital marketing operations. The Omnichannel Activation solutions segment helps life sciences companies to leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. The Others segment offers enterprise clinical solutions and consultancy services. The company was founded by Manish Gupta, Rajesh Bhaskaran Nair, Sanjay Suresh Parikh, Gaurav Kapoor, and Anand Kiran on October 16, 1998 and is headquartered in Bangalore, India. | 16 Jahre |
| Tarun Mathur | M | - |
Indegene Ltd.
Indegene Ltd. Miscellaneous Commercial ServicesCommercial Services Indegene Ltd. engages in the provision of healthcare support, media, and technology services to the pharmaceutical and biotechnology sectors. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation and Others segment. The Enterprise Medical Solutions segment establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The Enterprise Commercial Solutions segment involves in assisting life sciences companies with their digital marketing operations. The Omnichannel Activation solutions segment helps life sciences companies to leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. The Others segment offers enterprise clinical solutions and consultancy services. The company was founded by Manish Gupta, Rajesh Bhaskaran Nair, Sanjay Suresh Parikh, Gaurav Kapoor, and Anand Kiran on October 16, 1998 and is headquartered in Bangalore, India. | 19 Jahre |
| Thomas G. MacNamara | M | - |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 17 Jahre |
| Suhas Prabhu | M | - |
Indegene Ltd.
Indegene Ltd. Miscellaneous Commercial ServicesCommercial Services Indegene Ltd. engages in the provision of healthcare support, media, and technology services to the pharmaceutical and biotechnology sectors. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation and Others segment. The Enterprise Medical Solutions segment establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The Enterprise Commercial Solutions segment involves in assisting life sciences companies with their digital marketing operations. The Omnichannel Activation solutions segment helps life sciences companies to leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. The Others segment offers enterprise clinical solutions and consultancy services. The company was founded by Manish Gupta, Rajesh Bhaskaran Nair, Sanjay Suresh Parikh, Gaurav Kapoor, and Anand Kiran on October 16, 1998 and is headquartered in Bangalore, India. | 19 Jahre |
| Amy Brennan | F | - |
Corporate Call Center, Inc.
 Corporate Call Center, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Call Center, Inc. provides multi-channel contact solutions. It specializes in supporting the full customer lifecycle of sales, service and retention for the insurance, healthcare and pharmaceutical services sectors. The firm offers physician referrals, class registration, triage, outpatient procedure scheduling and administrative calls. The company was founded by Claudia Timbo in 2002 and is headquartered in Blue Bell, PA. | - |
| Jim Gallagher | M | - |
Corporate Call Center, Inc.
Corporate Call Center, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Call Center, Inc. provides multi-channel contact solutions. It specializes in supporting the full customer lifecycle of sales, service and retention for the insurance, healthcare and pharmaceutical services sectors. The firm offers physician referrals, class registration, triage, outpatient procedure scheduling and administrative calls. The company was founded by Claudia Timbo in 2002 and is headquartered in Blue Bell, PA. | - |
| Bina Patil | F | - |
Indegene Ltd.
Indegene Ltd. Miscellaneous Commercial ServicesCommercial Services Indegene Ltd. engages in the provision of healthcare support, media, and technology services to the pharmaceutical and biotechnology sectors. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation and Others segment. The Enterprise Medical Solutions segment establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The Enterprise Commercial Solutions segment involves in assisting life sciences companies with their digital marketing operations. The Omnichannel Activation solutions segment helps life sciences companies to leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. The Others segment offers enterprise clinical solutions and consultancy services. The company was founded by Manish Gupta, Rajesh Bhaskaran Nair, Sanjay Suresh Parikh, Gaurav Kapoor, and Anand Kiran on October 16, 1998 and is headquartered in Bangalore, India. | 19 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Vin Milano Milano | M | 60 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 18 Jahre |
| Howard H. Pien | M | 66 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 12 Jahre |
| Claude H. Nash | M | - |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | - |
| Michel de Rosen | M | 73 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 8 Jahre |
| Laureen Seeger | F | 62 | 14 Jahre | |
| Thomas A. Bologna | M | 76 |
Ostex International, Inc.
| 6 Jahre |
| Robert A. Doody | M | - |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 8 Jahre |
| Michael Dougherty | M | 66 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 10 Jahre |
| Richard Morris | M | 51 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 13 Jahre |
| Mark Walchirk | M | 68 | 16 Jahre | |
| Paul Brooke | M | 77 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 13 Jahre |
| Mark A. Pulido | M | 72 | 3 Jahre | |
| Charles Rowland | M | 65 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 6 Jahre |
| Alton Irby | M | 83 | 17 Jahre | |
| John Peter Wolf | M | 54 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 10 Jahre |
| M. Christine Jacobs | F | 73 | 22 Jahre | |
| John Leone | M | 77 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 8 Jahre |
| William D. Claypool | M | 72 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | - |
| Nigel A. Rees | M | 78 | 15 Jahre | |
| Simon Benito | M | 79 |
Merck Human Health US
| 7 Jahre |
| Scott Bagwell | M | - | 5 Jahre | |
| Robert G. Pietrusko | M | 76 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | - |
| Paul Firuta | M | 58 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 6 Jahre |
| Allen Hodge | M | - |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 3 Jahre |
| Alan Clock | M | - | 3 Jahre | |
| Assaf Morag | M | - | 4 Jahre | |
| Stephen Ruddy | M | 60 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 2 Jahre |
| Steven Gelone | M | 56 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 9 Jahre |
| Walter J. Kaczmarek | M | 65 | 6 Jahre | |
| Robert Clayton Fletcher | M | 61 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 13 Jahre |
| Julie McHugh | F | 59 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 2 Jahre |
| Jennifer Schranz | M | 59 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 3 Jahre |
| Suzanne Passalacqua | F | - | 1 Jahre | |
| Kevin McAdams | M | - | 3 Jahre | |
| Jeffrey Dayno | M | 66 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 3 Jahre |
| Ellen Rosenberg | F | 61 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 8 Jahre |
| Bruce J. Haupt | M | - | - | |
| John J. Kirby | M | 52 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 2 Jahre |
| Nancy Brown | F | 63 | 5 Jahre | |
| Jeffrey J. Miller | M | - |
Ostex International, Inc.
| 1 Jahre |
| Tom Rodgers | M | 53 | 5 Jahre | |
| James V. Napier | M | 87 | 10 Jahre | |
| Paul E. Kirincic | M | 73 | - | |
| Charles Norris | M | 77 | 10 Jahre | |
| Colin Broom | M | 68 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 10 Jahre |
| Thomas D. Underwood | M | 65 | 3 Jahre | |
| Steven J. Rosenberg | M | 68 | 5 Jahre | |
| James A. Nash | M | 73 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 6 Jahre |
| Joshua M. Tarnoff | M | 60 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | - |
| Ganesh Kumar | M | 59 | 2 Jahre | |
| Matthew Plavan | M | 60 | 7 Jahre | |
| Frank Baldino | M | 71 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 1 Jahre |
| Aldo Zini | M | - | 3 Jahre | |
| William Dawson | M | 69 | 3 Jahre | |
| William R. Graber | M | 80 | 4 Jahre | |
| Dan Eckert | M | 59 | 6 Jahre | |
| Thomas A. Capizzi | M | - | 2 Jahre | |
| Richard J. Hernandez | M | 80 | 5 Jahre | |
| Martin Driscoll | M | 65 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 2 Jahre |
| Alan M. Pearce | M | 75 | 5 Jahre | |
| Don Soland | M | 65 |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | 8 Jahre |
| Arthur Chong | M | 70 | 6 Jahre | |
| Kevin Swan | M | - | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 66 | 94,29% |
| Indien | 4 | 5,71% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Robert J. Glaser
- Persönliches Netzwerk
